Stop using

LUFA Advanced Pain Relief Gel Batch 25C372 (DRAP alert)

LUFA

DRAP Rapid Alert 128 states LUFA Advanced Pain Relief Gel batch 25C372 contained undeclared betamethasone and was marketed without registration. Stop that batch. This is a pharmaceutical adulteration finding, not a cosmetic ingredient-list check.

Regulatory alert

DRAP Rapid Alert 128, batch 25C372. Finding is undeclared betamethasone in that sample β€” not a statement about every pain gel on the market.

ActionWhat to do now

Stop LUFA gel batch 25C372 β€” DRAP found undeclared betamethasone

DRAP Rapid Alert 128 states LUFA Advanced Pain Relief Gel batch 25C372 contained undeclared betamethasone and was marketed without registration. Stop that batch. This is a pharmaceutical adulteration finding, not a cosmetic ingredient-list check.

Watch for: Betamethasone (undeclared)

Regulatory alert
See safer alternatives

EvidenceStatus & sample scope

DRAP Rapid Alert 128 states LUFA Advanced Pain Relief Gel batch 25C372 contained undeclared betamethasone and was marketed without registration. Stop that batch. This is a pharmaceutical adulteration finding, not a cosmetic ingredient-list check.

DRAP Rapid Alert 128, batch 25C372. Finding is undeclared betamethasone in that sample β€” not a statement about every pain gel on the market.

Regulatory alert

KhulasaSimple summary

DRAP Rapid Alert ke mutabiq LUFA Advanced Pain Relief Gel batch 25C372 mein undeclared betamethasone detect hua. Yeh unregistered/falsified product hai β€” is batch ko use na karein, khaas tor par chehre par.

UnderstandWhy this matters

EvidenceTest results & regulatory timeline

RegulatoryTimeline

  1. 2026DRAP Rapid Alert 128 β€” undeclared betamethasone identified in LUFA Advanced Pain Relief Gel batch 25C372; product declared unregistered/falsified

    View source

Ingredients to watch

βœ— Dangerous / avoid

  • Betamethasone (undeclared in batch 25C372)

βœ“ Safer patterns

  • Use only registered pain gels with a declared active
  • Do not apply undeclared steroid gels on the face

Health concernsWhen this may apply

  • Skin thinning, steroid acne, and pigmentation rebound

    Applies when an undeclared or unsupervised corticosteroid is used as a daily fairness or β€œnormal” cream, especially on the face.

    DRAP Rapid Alert 128; NHS topical steroids
  • Delayed infection healing and dependency

    Applies with prolonged unsupervised use; stopping suddenly after long misuse can cause rebound redness and burning.

    DRAP Rapid Alert 128; NHS topical steroids

VerifyVerification checklist

  • DRAP recall / rapid-alert page par product name aur batch number milaan
  • Fairness cream ko ordinary cosmetic na samjhein β€” undeclared steroid possible hai
  • Prescription steroid (Betnovate type) ko fairness ke liye use na karein
  • Agar lambi muddat use ho chuki ho to abrupt stop se pehle doctor se baat karein
  • Packaging, batch, seller details report ke liye save karein

For ordinary cosmetics, check DRAP's public safety alerts and recalled-product notices for this brand β€” not every cosmetic requires a registration-number lookup.

This product is treated as medicated/therapeutic β€” confirm DRAP registration on the pack if applicable.

ContextWhat users are trying to achieve

  • Using an unregistered pain gel on the face for fairness or β€œglow”
  • Long-term unsupervised application on large skin areas
  • Ignoring a DRAP rapid alert because the product is not a cream jar

RecoverWhat to do if you've already used it

Choose differentlySafer next steps

OuterDerm picks

CommunityReport this product